Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3105098
Max Phase: Preclinical
Molecular Formula: C28H35NO6
Molecular Weight: 481.59
Molecule Type: Small molecule
Associated Items:
ID: ALA3105098
Max Phase: Preclinical
Molecular Formula: C28H35NO6
Molecular Weight: 481.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CNc1ccccc1C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C
Standard InChI: InChI=1S/C28H35NO6/c1-14-12-27-15(2)10-19-21(26(19,3)4)18(23(27)32)11-16(13-30)22(31)28(27,34)24(14)35-25(33)17-8-6-7-9-20(17)29-5/h6-9,11-12,15,18-19,21-22,24,29-31,34H,10,13H2,1-5H3/t15-,18+,19-,21+,22-,24+,27+,28+/m1/s1
Standard InChI Key: GBNPWIIHHOENSI-YXKOJEMPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 481.59 | Molecular Weight (Monoisotopic): 481.2464 | AlogP: 2.72 | #Rotatable Bonds: 4 |
Polar Surface Area: 116.09 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.13 | CX Basic pKa: 2.12 | CX LogP: 2.91 | CX LogD: 2.91 |
Aromatic Rings: 1 | Heavy Atoms: 35 | QED Weighted: 0.39 | Np Likeness Score: 2.53 |
1. Grue-Sørensen G, Liang X, Månsson K, Vedsø P, Dahl Sørensen M, Soor A, Stahlhut M, Bertelsen M, Engell KM, Högberg T.. (2014) Synthesis, biological evaluation and SAR of 3-benzoates of ingenol for treatment of actinic keratosis and non-melanoma skin cancer., 24 (1): [PMID:24332494] [10.1016/j.bmcl.2013.11.073] |
Source(1):